In 1996 Jan Theys started his research as a PhD student in Leuven. In short: he uses the non-pathogenic bacterium Clostridium to ‘transport’ a chemotherapeutic drug to the tumor.
Read the article:
https://www.brightlands.com/en/brightlands-maastricht-health-campus/about/experts-healthcare/persoon/expert-jan-theys